Monsanto retreats from bold profit goal

Monsanto shares rallied to a record in November 2007 when executives declared the company would double gross profit in five years.

As recently as January, CEO Hugh Grant and other senior managers insisted they were on track to meet the goal. After all, Monsanto’s queue was stocked with promising new seed technologies to help meet a growing demand for food.

But on Wednesday, Grant retreated, saying the company won’t meet its 2012 target of gross profit, which is a company’s sales less the cost of the goods and services sold.

“Moving away from our original set of goals is difficult for us to accept, but it’s the right thing to acknowledge now,” he said in a conference call with analysts and investors.

The announcement caps a turbulent past year for Monsanto. The Creve Coeur-based company is the subject of a federal antitrust investigation. It was forced to shed hundreds of jobs and slash prices for its best-selling weed killer because of a glut of generic product from China. And it isn’t selling as much of its new biotech corn and soybean seed as expected because some growers have balked at the higher price.

However painful to do, backing off its 2012 profit pledge was the right choice in the long run, analysts said.

“We don’t like it when we see companies do unwise things to meet a near-term goal at the expense of long-term growth,” said Dan Ortwerth, an analyst at Edward Jones.

Monsanto’s lower outlook came as the company reported on Wednesday a 19-percent drop in fiscal second-quarter earnings.
Monsanto’s net income — gross profit less all other costs — fell to $887 million, or $1.60, for the quarter ended Feb. 28, versus $1.09 billion, or $1.97, in the same three months a year ago. Sales fell 3.6 percent to $3.89 billion.

Excluding costs related to a corporate restructuring last year, Monsanto’s earnings matched the $1.70-a-share average estimate of analysts surveyed by Bloomberg.
RELATED LINKS
Get more business news, blogs and opinion

Monsanto said full-year profit would be at the low end of the previously announced range of $3.10 to $3.30 a share. The company forecast earnings growth of 13 percent to 17 percent a year beginning in 2011 — a much slower rate than investors had been accustomed to.

The company’s stock slid 2 percent on Wednesday to $68.09 on the New York Stock Exchange. That’s less than half its all-time high of $142.69 set in June 2008. So far this year, the stock has fallen 17 percent.

The biggest drag on Monsanto’s profitability since then has been the decline in its Roundup business.

On Wednesday, Monsanto further cut gross profit projections for its Roundup business to $600 million, from $650 million to $750 million. Only a year ago, the same segment generated $1.8 billion in gross profit.

The reason for the steep drop in Roundup profit: a flood of Chinese-made generic weed killer saturating the U.S. market that forced Monsanto to slash prices.

Just a week ago, the nation’s only other glyphosate manufacturer, Ankeny, Iowa-based Albaugh Inc., filed an anti-dumping petition with the U.S. government.

Monsanto faces competitive pressure in the seed business too.

As a result, the company indicated that it would retool its product strategy, a move that will include some price cuts, to drive higher adoption rates for new products.

Monsanto said earlier this year that its new SmartStax corn and Roundup Ready 2 Yield soybeans would be planted on fewer acres than previously forecast.


cont.